Latest Breaking News On - Douwe miedema - Page 1 : comparemela.com

PolTREG S A : PolTREG identifies promising efficacy biomarker for Type-1 diabetes in patients treated with its Treg therapy in combination with rituximab

PolTREG S A : PolTREG identifies promising efficacy biomarker for Type-1 diabetes in patients treated with its Treg therapy in combination with rituximab
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Piotr trzonkowskiDennis riedlDouwe miedemaChris maggosCohesion bureauInternational immunopharmacologyPoltreg sa warsaw stock exchangeWarsaw stock exchangeMultiple sclerosis

PolTREG identifies promising efficacy biomarker for Type-1 diabetes in patients treated with its Treg therapy in combination with rituximab

PolTREG identifies promising efficacy biomarker for Type-1 diabetes in patients treated with its Treg therapy in combination with rituximab
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Chris maggosPiotr trzonkowskiDouwe miedemaInternational immunopharmacologyPoltreg sa warsaw stock exchangeCohesion bureauWarsaw stock exchangeMultiple sclerosis

PolTREG S A : PolTREG receives CGMP certification to produce cell therapies at its state-of-the-art manufacturing site in Poland

PolTREG S A : PolTREG receives CGMP certification to produce cell therapies at its state-of-the-art manufacturing site in Poland
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Stefan klotterPiotr trzonkowskiDouwe miedemaChris maggosPoland office for registration of medicinal productsPoltreg sa warsaw stock exchangeCohesion bureauWarsaw stock exchangeChief pharmaceutical inspectorateAdvanced therapy medicinal productsMedicinal productsMedical devicesBiocidal productsMultiple sclerosisChief executive officerAmyotrophic lateral sclerosis

PolTREG receives CGMP certification to produce cell therapies at its state-of-the-art manufacturing site in Poland

Gdańsk, Poland – 11 March 2024 – PolTREG S.A. , a clinical-stage biotechnology company developing cellular therapies for a range of autoimmune diseases, today announces it has received CGMP.

Douwe miedemaPiotr trzonkowskiChris maggosGlobenewswire incPoltreg sa warsaw stock exchangeOffice for registration of medicinal productsCohesion bureauWarsaw stock exchangeChief pharmaceutical inspectorateAdvanced therapy medicinal productsMedicinal productsMedical devicesBiocidal productsMultiple sclerosisChief executive officerAmyotrophic lateral sclerosis

PolTREG appoints Dan Shelly as Chief Business Development Officer

PolTREG appoints Dan Shelly as Chief Business Development Officer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Daniel shellyPiotr trzonkowskiDouwe miedemaChris maggosPrescient therapeutics ltdPoltreg sa warsaw stock exchangeCohesion bureauUniversity of cincinnatiGlobal business developmentBusiness developmentDan shellyChief business developmentWarsaw stock exchangeChief business development officerMultiple sclerosisAmyotrophic lateral sclerosis